BDTX Latest Press Releases

-- May 22, 2026 --

Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference Globe Newswire 8:00 AM

-- May 21, 2026 --

Black Diamond Therapeutics Announces Positive Phase 2 Results for Silevertinib in Frontline NSCLC Patients with EGFR Non-Classical Mutations Globe Newswire 5:13 PM

-- May 19, 2026 --

Black Diamond Therapeutics to Host Webcast for Investors Highlighting Updated Results from Phase 2 Trial of Silevertinib in 1L EGFRm NSCLC Globe Newswire 8:00 AM

-- May 7, 2026 --

Black Diamond Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 7:30 AM

-- April 21, 2026 --

Black Diamond Therapeutics Announces Oral Presentation of Silevertinib Phase 2 Data in Frontline EGFRm NSCLC Patients at the 2026 ASCO Annual Meeting Globe Newswire 10:40 AM

-- March 16, 2026 --

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update Globe Newswire 4:01 PM

-- March 2, 2026 --

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences Globe Newswire 4:01 PM

-- February 11, 2026 --

EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight PRNewswire 5:31 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software